Tag: #EarlyDetection

  • Understanding Nasopharyngeal Cancer: Symptoms, Diagnosis, and Treatment

    Understanding Nasopharyngeal Cancer: Symptoms, Diagnosis, and Treatment

    KUALA LUMPUR, 10 February 2026 – Nasopharyngeal cancer (NPC) is a type of cancer that originates in the nasopharynx, the area behind the nose and above the back of the throat. Its concealed location and subtle early symptoms, such as persistent nasal congestion, nosebleeds, fluid in the middle ear, ringing, or painless neck lumps, often result in delayed diagnosis. Many patients are initially treated for sinusitis, allergies, or ear infections before NPC is considered. In Malaysia, NPC is particularly prevalent among men aged 40 to 60, and individuals of Asian descent, with genetic susceptibility, Epstein-Barr virus infection, and diet high in preserved foods contributing to risk.

    According to Dr Hafizah Zaharah Ahmad of Sunway Medical Centre Velocity (SMCV), early detection is crucial for improved survival rates. Diagnosis begins with nasoendoscopy to visualise the nasopharynx, followed by MRI or CT scans to assess tumor size, local invasion, and soft tissue involvement. Dr David Yee Leong Wai, ENT and Head & Neck Surgeon at SMCV, highlights that biopsy remains essential for confirming diagnosis and grading the tumor histologically, which helps guide treatment.

    Treatment varies depending on disease stage. Early-stage NPC may be treated with radiotherapy alone, whereas locally advanced cases typically require concurrent chemotherapy and radiotherapy. Modern radiotherapy techniques, including Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy, allow precise targeting of the tumor while protecting surrounding critical structures such as nerves, salivary glands, and the brainstem. Surgery is generally reserved for residual or recurrent tumors, with endoscopic approaches through the nasal passages reducing trauma and promoting recovery.

    Patients may experience side effects like fatigue, nausea, and oral ulcers, which are managed with supportive care, nutritional guidance, and close monitoring. Post-treatment follow-up with ENT specialists and oncologists ensures early detection of recurrence. Awareness of NPC’s early symptoms, timely investigation, and advances in treatment collectively improve survival rates and quality of life for patients.

  • CarePod by Cempaka Cahaya Revolutionizes Preventive Healthcare in Malaysia

    CarePod by Cempaka Cahaya Revolutionizes Preventive Healthcare in Malaysia

    Cempaka Cahaya Sdn. Bhd. has launched CarePod, a next-generation AI-enabled healthcare kiosk aimed at improving preventive care and early disease detection in Malaysia. The launch, graced by Dato’ Dr. Suhaimi bin Ibrahim, Pengerusi KOBENA, underscored strong institutional and community support for transforming primary healthcare services through digital integration.

    Developed by DR Solutions, CarePod is a fully integrated platform offering real-time vital sign monitoring, Point-of-Care Testing (including FBC, biochemistry panels, HbA1c), rapid screening for Malaria, Influenza, and Dengue, AI-assisted clinical workflows, secure teleconsultations, and digital follow-up pathways. This holistic model decentralizes healthcare delivery without compromising clinical governance, patient data security, or accountability.

    CarePod’s digital infrastructure is strengthened by QuantumNexis Sdn. Bhd., ensuring scalable, enterprise-grade cloud services and compliance with international standards. The system also collaborates with University of Malaya to enable evidence-based outcomes, NCD risk profiling, and infectious disease analytics for continuous improvement.

    Dr. Balachandran Krishnan, CEO of Cempaka Cahaya Sdn. Bhd., explained that CarePod marks a move from reactive treatment to proactive preventive care. “By integrating AI-driven diagnostics and teleconsultation into a secure ecosystem, CarePod reduces diagnostic delays, enables earlier intervention, and expands access to structured healthcare services—especially for semi-urban and rural populations,” he said. CarePod allows structured screening for hypertension, cardiovascular disease, diabetes, metabolic disorders, and respiratory compromise while providing rapid infectious disease testing.

    This initiative represents a significant step in making preventive healthcare more accessible and efficient, leveraging AI, digital integration, and academic collaboration to improve health outcomes nationwide.

  • Men, Let’s Talk Cancer: The Top 3 Deadliest Types Every Man Needs to Know

    Men, Let’s Talk Cancer: The Top 3 Deadliest Types Every Man Needs to Know

    Late nights, fast food, long working hours, and little exercise have become common for many men, but these habits are quietly contributing to a worrying health trend. According to the Malaysia National Cancer Registry Report 2017–2021, the lifetime risk of Malaysian men developing cancer has risen from 1 in 10 to 1 in 8, with colorectal, lung, and prostate cancers topping the list. While genetics play a role, lifestyle choices remain the biggest factor. “Only about five to ten percent of cancers are hereditary,” explains Dr Hafizah Zaharah Ahmad, Consultant Clinical Oncologist at Sunway Medical Centre Velocity (SMCV). “For the majority, our daily habits — what we eat, how active we are, and our commitment to screenings — make the biggest difference.”

    Modern lifestyles often foster habits that silently harm long-term health. Prolonged sitting, processed diets, and limited physical activity can lead to obesity, chronic inflammation, and hormonal imbalances, creating conditions conducive to tumor growth. High intake of processed and red meats further compounds the risk, yet many men dismiss early warning signs due to social stigma or embarrassment, particularly regarding urinary or reproductive health. Dr Goh Cheng Hood, Consultant Urologist at SMCV, warns that such hesitation can result in late-stage diagnosis, limiting treatment options and reducing survival chances.

    Colorectal cancer, the most common cancer among Malaysian men, often begins as small polyps that may turn cancerous over 5–10 years. Diets low in fiber and high in red or processed meats, along with physical inactivity and smoking, increase risk. Early detection through colonoscopy significantly improves outcomes, while dietary and lifestyle adjustments — including reducing red meat and quitting smoking — can lower risk.

    Lung cancer, closely linked to smoking, remains one of the deadliest cancers among men. Exposure to carcinogenic chemicals damages DNA and triggers inflammation, yet early symptoms such as cough or fatigue are often ignored, with over 95% of cases diagnosed at advanced stages.

    Dr. Hafizah Zaharah

    Prostate cancer develops slowly, often mimicking benign prostate enlargement and remaining asymptomatic until later stages. Men over 58, those taking testosterone supplements, or carrying the BRCA2 gene face higher risk. Regular screening with the Prostate-Specific Antigen (PSA) blood test, starting from age 50 (or 40 for high-risk individuals), allows early detection and can extend life expectancy by up to 15 years in early-detected cases.

    Experts stress that cancer prevention is largely within one’s control. Maintaining a balanced diet rich in fruits, vegetables, and whole grains, exercising regularly, staying hydrated, managing stress, avoiding smoking, and limiting alcohol intake all support healthy cell function and reduce cancer risk. Combining healthy lifestyle habits with timely screenings such as colonoscopy, low-dose CT scans for smokers, and annual health checks can detect abnormalities early, when treatment is most effective.

    Dr. Goh Cheng Hood

    While cancer rates among Malaysian men continue to rise, awareness, prevention, and early action offer the strongest defense. Sunway Medical Centre Velocity continues to champion men’s health through multidisciplinary care and public education, emphasizing that taking charge of one’s wellbeing today is the key to a longer, healthier future. For more information, visit www.sunmedvelocity.com.my or contact SMCV at +603 9772 9191.